FDA Inspection 1268746 — Hubei Honch Pharmaceutical Co, Ltd.
The FDA completed an inspection of Hubei Honch Pharmaceutical Co, Ltd. on Mar 20, 2025 in Huanggang. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 20, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Huanggang (China)